-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on Pediatrix Medical Group, Raises Price Target to $23

Benzinga·11/05/2025 23:17:55
Listen to the news
UBS analyst A.J. Rice maintains Pediatrix Medical Group (NYSE:MD) with a Neutral and raises the price target from $16.5 to $23.